Skip Nav Destination
Eltrombopag: wielding a double-edged sword?
Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag
With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study
Issue Archive
Table of Contents
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
Eltrombopag: wielding a double-edged sword?
Clinical Trials & Observations
PLENARY PAPER
THROMBOSIS AND HEMOSTASIS
The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing
Jun Ishihara,Ako Ishihara,Richard D. Starke,Claire R. Peghaire,Koval E. Smith,Thomas A. J. McKinnon,Yoji Tabata,Koichi Sasaki,Michael J. V. White,Kazuto Fukunaga,Mike A. Laffan,Matthias P. Lutolf,Anna M. Randi,Jeffrey A. Hubbell
BLOOD SPOTLIGHT
CLINICAL TRIALS AND OBSERVATIONS
Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag
Clinical Trials & Observations
Thomas Winkler,Xing Fan,James Cooper,Ronan Desmond,David J. Young,Danielle M. Townsley,Phillip Scheinberg,Sophia Grasmeder,Andre Larochelle,Marie Desierto,Janet Valdez,Jennifer Lotter,Colin Wu,Ruba N. Shalhoub,Katherine R. Calvo,Neal S. Young,Cynthia E. Dunbar
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center
Giuliana Giardino,Nesrine Radwan,Patra Koletsi,Deborah M. Morrogh,Stuart Adams,Winnie Ip,Austen Worth,Alison Jones,Imke Meyer-Parsonson,H. Bobby Gaspar,Kimberly Gilmour,E. Graham Davies,Fani Ladomenou
LYMPHOID NEOPLASIA
Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells
Stefanie Sperling,Petra Fiedler,Markus Lechner,Anna Pollithy,Stefanie Ehrenberg,Ana-Iris Schiefer,Lukas Kenner,Annette Feuchtinger,Ralf Kühn,Gene Swinerd,Marc Schmidt-Supprian,Lothar J. Strobl,Ursula Zimber-Strobl
LETTERS TO BLOOD
With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study
Clinical Trials & Observations
Nathanael R. Fillmore,Sarvari V. Yellapragada,Chizoba Ifeorah,Ansh Mehta,Diana Cirstea,Paul S. White,Gustavo Rivero,Andrew Zimolzak,Saiju Pyarajan,Nhan Do,Mary Brophy,Nikhil C. Munshi
Archeogenetics of F11 p.Cys38Arg: a 5400-year-old mutation identified in different southwestern European countries
María Eugenia de la Morena-Barrio,Salam Salloum-Asfar,Julio Esteban,Belén de la Morena-Barrio,Carmen Altisent,Laura Martin-Fernández,Paul Gueguen,Jose Padilla,Antonia Miñano,Rafael Parra,Vicente Vicente,Francisco Vidal,Frederic Bauduer,Pablo Carbonell,Javier Corral
BLOOD WORK
ERRATUM
-
Cover Image
Cover Image
Spleen section of a mouse with constitutive active CD30 in B lymphocytes 14 days after T cell–dependent immunization. Germinal center (GC) cells, peanut agglutinin, and metallophilic macrophages are stained in blue, and B lymphocytes (immunoglobulin M) are stained in red. CD30 signaling blocks GC development, enhances plasma cell differentiation, and leads to lymphomagenesis in aged mice. See the article by Sperling et al on page 2597.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals